Adial Pharmaceuticals
ADIL
#10837
Rank
ยฃ10.13 M
Marketcap
ยฃ3.86
Share price
36.12%
Change (1 day)
1,584.90%
Change (1 year)

Earnings for Adial Pharmaceuticals (ADIL)

Earnings in 2026 (TTM): -ยฃ43.58 Million

According to Adial Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ6.1 Million, an increase over its 2024 earnings that were of -ยฃ10.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adial Pharmaceuticals from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ43.58 Million614.7%
2025 -ยฃ6.1 Million-39.56%
2024 -ยฃ10.09 Million88.48%
2023 -ยฃ5.36 Million-39.45%
2022 -ยฃ8.84 Million-40.76%
2021 -ยฃ14.92 Million79.17%
2020 -ยฃ8.33 Million26.79%
2019 -ยฃ6.57 Million-26.14%
2018 -ยฃ8.9 Million920.78%
2017 -ยฃ0.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-ยฃ1.66 Million-96.26% Bahamas
NRC Health
NRC
ยฃ11.3 M-125.59%๐Ÿ‡บ๐Ÿ‡ธ USA